Understand The Current Buy Rationale for Salesforce

Salesforce (CRM) experienced a 22% surge after the Q2, with the Agentforce and Data 360 combined ARR reaching $3.9 billion, a 210% increase year over year. Despite trading down 3% year to date, bulls argue that Salesforce's AI-based consumption upside is underpriced at 19 times forward earnings. The earnings beat was smaller than reported, as operating income remained flat year over year after stripping $2.43 per share from strategic investments, including Anthropic.

The stock's rally is driven by the Agentforce thesis, as Salesforce positions itself as the "Agentic Enterprise" platform, integrating various tools such as Agentforce AI agents, Data 360, Slack, MuleSoft, Tableau, and Informatica. The company's FY27 Q2 report shifted the conversation from AI eroding seat-based revenue to a reacceleration phase.

Revenue grew 10.83% to $11.345 billion, with Agentforce ARR surpassing $1.5 billion and guidance raised to $46.1 billion to $46.4 billion. Management expects non-GAAP operating margin to hit 34.3%. Free cash flow grew 81.49% to $1.098 billion, and the accelerated share repurchase reduced the share count to 821 million from 962 million.

Despite the positive outlook, Salesforce is yet to be included in the analyst's top AI stocks list, named by the analyst who correctly predicted NVIDIA in 2010. The stock trades at roughly 19 times forward earnings and 23 times trailing earnings, with an average price target of $262.54, implying a 3% upside. Factors that could accelerate the stock's growth include Agentforce ARR breaching $4 billion, constant currency cRPO growth staying above 14%, and premium-edition attach rates on ClaudeForce and Headless Salesforce.

The thesis relies on the durable rerating as consumption-based ARR compounds, with the timeframe for payoff ranging from 12 to 24 months.